Platelet glycoprotein IIb/IIIa inhibitor tirofiban in clopidogrel-naïve patients undergoing elective percutaneous coronary intervention.
Zarina HabibiJasper LuijkxBen C G GhoMustafa IlhanLeo F VeenstraLex A W RuitersMera SteinArnoud W J van 't HofSaman RasoulPublished in: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation (2023)
Ad-hoc PCI in clopidogrel-naïve patients who were treated with high-dose bolus of tirofiban followed by a clopidogrel loading dose immediately after the procedure appeared to be safe.
Keyphrases
- percutaneous coronary intervention
- acute coronary syndrome
- antiplatelet therapy
- patients undergoing
- st segment elevation myocardial infarction
- high dose
- acute myocardial infarction
- st elevation myocardial infarction
- coronary artery disease
- coronary artery bypass grafting
- low dose
- coronary artery bypass
- atrial fibrillation
- minimally invasive
- newly diagnosed